Dmitriy Ovcharenko
Dmitriy is a founder and CEO of Altogen Labs, a GLP-compliant contract organization providing custom R&D services in laboratory pre-clinical research, pharmacology/toxicology studies, bioremediation, gene silencing and RNA interference (RNAi). Dmitriy is a cell and molecular biologist by training, holding degrees in biology, ecology, pharmacology and toxicology. Dmitriy's main research interest is anticancer therapeutical application of microRNA, small molecules that regulate gene expression of networks of oncogenes. Therapeutical application of microRNA and siRNA oligonucleotides (a part of recently-discovered RNAi phemomena) holds promise for generation of novel gene-targeted medicines against many uncurable diseases. Member of the following professional organizations: American Association for Cancer Research, American Society for Cell Biology, and American Society for Pharmacology & Experimental Therapeutics.
Links:
American Association for Cancer Research American Society for Cell Biology
American Society for Pharmacology & Experimental Therapeutics
The Inner Life of a Cell - Cell biology 4D animation
RNAi - Mechanism of RNA Interference (RNAi)
NOVA scienceNOW RNAi - PBS describes biology of RNAi and medical applications
microRNA.ws - microRNA and cancer therapeutics website
RNA World - RNAi databases and software